Register for email alerts and news feeds:
This journal | BMJ Group
rss
Evidence-Based Mental Health 2009;12:107; doi:10.1136/ebmh.12.4.107
Copyright © 2009 by BMJ Publishing Group Ltd, Royal College of Psychiatrists, & British Psychological Society.

OTHER

Therapeutics

Review: clinically important differences between antidepressants

The first 150 words of the full text of this article appear below.

Question

Question:

What are the effects of the 12 most commonly prescribed new generation antidepressants for moderate to severe major depression in adults?

Outcomes:

Response to treatment at 8 weeks, defined as the proportion of patients having a 50% or greater reduction from baseline in Hamilton Depression Rating Scale or Montgomery–Asberg depression rating scale or those scoring "much improved" or "very much improved" on the clinical global impression; discontinuation as a measure of acceptability of treatment defined as the number of patients who terminated the study early for any reason during the first 8 weeks of treatment.

Methods

Design:

Systematic review with meta-analysis (pairwise with random effects model and mixed treatment meta-analysis).

Data sources:

Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials registers (searched November 2007).

Study selection and analysis:

Randomised controlled trials comparing any of the following new generation antidepressants being used as monotherapy to treat adults with unipolar major depression: duloxetine, velanfaxine, sertraline, bupropion, citalopram, escitalopram, fluoxetine, minacipran, . . . [Full text of this article]

R Hamish McAllister-Williams

Newcastle University, Newcastle upon Tyne, UK


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Making the best use of available evidence: the case of new generation antidepressants: A response to: Are all antidepressants equal?
Corrado Barbui, Andrea Cipriani, Toshiaki A Furukawa, Georgia Salanti, Julian P T Higgins, Rachel Churchill, Norio Watanabe, Atsuo Nakagawa, Ichiro M Omori, John R Geddes
Evid. Based Ment. Health 2009 12: 101-104. (in EBMH notebook) [Extract] [Full Text] [PDF]

Are all antidepressants equal?
G Gartlehner, B N Gaynes
Evid. Based Ment. Health 2009 12: 98-100. (in EBMH notebook) [Extract] [Full Text] [PDF]

This Article

Services
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Online Education

Psychiatry CPD/CME from The Royal College of Psychiatrists

Professional Development from The British Psychological Society